Bronstein, Gewirtz & Grossman, LLC Is Investigating Cerevel Therapeutics Holdings, Inc. (CERE) And Encourages Investors to Connect
NEW YORK, NY / ACCESS Newswire / December 7, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cerevel Therapeutics Holdings, Inc. ("Cerevel" or "the Company") (NASDAQ:CERE). Investors who purchased Cerevel securities prior to October 11, 2023, and continue to hold to the present, are encouraged to obtain […]